Macfarlane, Gary JBarnish, Maxwell SJones, Elizabeth AKay, LesleyKeat, AndrewMeldrum, Karen TPathan, EjazSturrock, Roger DZabke, ClaudiaMcNamee, PaulJones, Gareth T2015-11-242015-11-242015-11-11Macfarlane, G J, Barnish, M S, Jones, E A, Kay, L, Keat, A, Meldrum, K T, Pathan, E, Sturrock, R D, Zabke, C, McNamee, P & Jones, G T 2015, 'The British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study : Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatment', BMC Musculoskeletal Disorders, vol. 16, 347. https://doi.org/10.1186/s12891-015-0805-x1471-2474ORCID: /0000-0003-2322-3314/work/29064675ORCID: /0000-0003-0016-7591/work/83704038http://hdl.handle.net/2164/5246Acknowledgements Oversight of the study is provided by the BSR Registers Committee of which GJM and GTJ are members, together with investigators from BSRBR-RA, representatives from the BSR clinical affairs section and BSR independent members, currently, Alex MacGregor (University of East Anglia), Elaine Dennison (University of Southampton), Jon Packham (Keele University) and patient representatives Ailsa Bosworth and Debbie Cook. We acknowledge the contribution of the International Advisory Group members DesireƩ van der Heijde (Netherlands), Matthew Brown (Australia) and Walter Maksymowych (Canada). We thank Neil Basu (University of Aberdeen) for his role with regards to pharmacovigilance and the Robertson Centre for Biostatistics (University of Glasgow) for data management services. Author KTM is currently at the Tayside Clinical Trials Unit, University of Dundee. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.432783engSDG 3 - Good Health and Well-beingaxial spondyloarthropathyankylosing spondylitisbiologic therapysafetyinfectioncohortR MedicineRThe British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study : Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatmentJournal article10.1186/s12891-015-0805-x16